A new lawsuit filed by a watchdog group accuses federal judge Aileen Cannon of Florida of "burying the truth" about former special counsel Jack Smith's final reportA new lawsuit filed by a watchdog group accuses federal judge Aileen Cannon of Florida of "burying the truth" about former special counsel Jack Smith's final report

Trump-appointed judge accused of 'burying the truth' about explosive Jack Smith report

2026/02/10 09:58
2분 읽기

A new lawsuit filed by a watchdog group accuses federal judge Aileen Cannon of Florida of "burying the truth" about former special counsel Jack Smith's final report of his investigation into President Donald Trump.

The lawsuit, filed by watchdog group American Oversight, asks the Eleventh Circuit Court of Appeals to vacate Cannon's order prohibiting the release of Volume II of Smith's report to Congress about Trump's efforts to overturn the 2020 election results. Cannon ruled last December that the report could not be released, and gave the Trump administration a 60-day window to challenge any disclosures.

“We will not allow the president and his guard dogs to bury information that belongs to the American people,” Chioma Chukwu, American Oversight's executive director, said in a statement. “For more than a year, Judge Cannon has kept the Special Counsel’s final report under seal, long after any legitimate claims by Trump’s co-conspirators expired. By blocking our effort to challenge her gag order, the court handed President Trump a roadmap for burying the report through delay and procedural gamesmanship."

The lawsuit was filed about a month after Smith testified to Congress that he believes he could be convicted of the same charges today. Smith also said the only reason Trump was not convicted is that he ran out the clock and was elected president in 2024.

"As Special Counsel Jack Smith recently testified, the report documents powerful evidence that the president willfully retained highly classified information after leaving office, putting national security at risk," Chukwu said. "We are seeking immediate relief to reverse Judge Cannon’s decision and prevent her from ruling on motions that would permanently erase this report from the historical record. The public deserves the truth, not a justice system that can be manipulated to hide it.”

시장 기회
OFFICIAL TRUMP 로고
OFFICIAL TRUMP 가격(TRUMP)
$3.287
$3.287$3.287
-2.02%
USD
OFFICIAL TRUMP (TRUMP) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, service@support.mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

추천 콘텐츠

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
공유하기
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
공유하기
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
공유하기
BitcoinEthereumNews2025/09/18 05:26